153 related articles for article (PubMed ID: 18399339)
1. Childhood Wilms' tumour: prognostic factors in North Central Nigeria.
Uba AF; Chirdan LB
West Afr J Med; 2007; 26(3):222-5. PubMed ID: 18399339
[TBL] [Abstract][Full Text] [Related]
2. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Acha T; Godzinski J; Oldenburger F; Boccon-Gibod L; Leuschner I; Vujanic G; Sandstedt B; de Kraker J; van Tinteren H; Graf N;
Lancet; 2015 Sep; 386(9999):1156-64. PubMed ID: 26164096
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and Clinical Outcomes of Children With Wilms' Tumour: A 15-year Experience in a Single Centre in Nigeria.
Nasir AA; Abdur-Raheem NT; Abdur-Rahman LO; Ibiyeye TT; Sayomi TO; Adedoyin OT; Adeniran JO
J Pediatr Surg; 2024 May; 59(5):1009-1014. PubMed ID: 38184433
[TBL] [Abstract][Full Text] [Related]
4. The challenge of nephroblastoma in a developing country.
Ekenze SO; Agugua-Obianyo NE; Odetunde OA
Ann Oncol; 2006 Oct; 17(10):1598-600. PubMed ID: 16873431
[TBL] [Abstract][Full Text] [Related]
5. MANAGEMENT AND OUTCOME OF PATIENTS WITH WILMS' TUMOUR (NEPHROBLASTOMA) AT THE MOI TEACHING AND REFERRAL HOSPITAL, ELDORET, KENYA.
Tenge CN; Were PA; Aluoch LH; Wekesa JW; Patel K; Kuremu RT
East Afr Med J; 2012 Apr; 89(4):121-7. PubMed ID: 26856036
[TBL] [Abstract][Full Text] [Related]
6. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
Mitchell C; Pritchard-Jones K; Shannon R; Hutton C; Stevens S; Machin D; Imeson J; Kelsey A; Vujanic GM; Gornall P; Walker J; Taylor R; Sartori P; Hale J; Levitt G; Messahel B; Middleton H; Grundy R; Pritchard J;
Eur J Cancer; 2006 Oct; 42(15):2554-62. PubMed ID: 16904312
[TBL] [Abstract][Full Text] [Related]
7. Risk stratification and consecutive prognosis progresses in childhood Wilms tumors. Two cases report.
Diaconescu S; Olaru C; Mihailă D; Aprodu SG; Miron I
Chirurgia (Bucur); 2013; 108(1):106-11. PubMed ID: 23464780
[TBL] [Abstract][Full Text] [Related]
8. Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology-Trial and Study "SIOP-9". International Society of Paediatric Oncology Nephroblastoma Trial and Study Committee.
Godzinski J; Tournade MF; deKraker J; Lemerle J; Voute PA; Weirich A; Ludwig R; Rapala M; Skotnicka G; Gauthier F; Moorman-Voestermans CG; Buerger D; VanVeen A; Sawicz-Birkowska K
Eur J Pediatr Surg; 1998 Apr; 8(2):83-6. PubMed ID: 9617606
[TBL] [Abstract][Full Text] [Related]
9. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
[TBL] [Abstract][Full Text] [Related]
10. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F
Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848
[TBL] [Abstract][Full Text] [Related]
11. Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group.
Pritchard-Jones K; Kelsey A; Vujanic G; Imeson J; Hutton C; Mitchell C; ;
J Clin Oncol; 2003 Sep; 21(17):3269-75. PubMed ID: 12947062
[TBL] [Abstract][Full Text] [Related]
12. Challenges and outcome of Wilms' tumour management in a resource-constrained setting.
Wilde JC; Lameris W; van Hasselt EH; Molyneux EM; Heij HA; Borgstein EG
Afr J Paediatr Surg; 2010; 7(3):159-62. PubMed ID: 20859020
[TBL] [Abstract][Full Text] [Related]
13. Results of Wilms' tumour management in two tertiary-care hospitals in Asia.
Sen S; Kadamba P; Al-AbdulAaly M; Mammen KE; Ahmed S
Pediatr Surg Int; 1998 Jan; 13(1):42-4. PubMed ID: 9391203
[TBL] [Abstract][Full Text] [Related]
14. Clinical presentation and treatment outcome in children with nephroblastoma in Kenya.
Abdallah FK; Macharia WM
East Afr Med J; 2001 Jul; 78(7 Suppl):S43-7. PubMed ID: 11957249
[TBL] [Abstract][Full Text] [Related]
15. Outcome of children with cystic partially differentiated nephroblastoma treated with or without chemotherapy.
Blakely ML; Shamberger RC; Norkool P; Beckwith JB; Green DM; Ritchey ML;
J Pediatr Surg; 2003 Jun; 38(6):897-900. PubMed ID: 12778388
[TBL] [Abstract][Full Text] [Related]
16. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
Stefanowicz J; Sierota D; Balcerska A; Stoba C
Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological study of nephroblastomas in Ibadan.
Akang EE; Okpala JU; Iliyasu Y; Lawani J
Br J Urol; 1992 Sep; 70(3):318-21. PubMed ID: 1330195
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-vincristine therapy for Wilms' tumor: a pilot study.
Camitta B; Kun L; Glicklich M; Oechler H; Adair S; Pinkel D
Cancer Treat Rep; 1982 Oct; 66(10):1791-4. PubMed ID: 6290049
[TBL] [Abstract][Full Text] [Related]
19. Wilms' tumor: a 10 year retrospective study.
Seyed-Ahadi MM; Khaleghnejad-Tabari A; Mirshemirani A; Sadeghian N; Amonollahi O
Arch Iran Med; 2007 Jan; 10(1):65-9. PubMed ID: 17198457
[TBL] [Abstract][Full Text] [Related]
20. [Histologic and prognostic study of nephroblastoma in central Tunisia].
Amel L; Leila BF; Lamia K; Olfa G; Abdelfattah Z; Mondher G; Faouzi M; Chakib K; Abdelatif N; Amor G; Slim BA
Ann Urol (Paris); 2003 Aug; 37(4):164-9. PubMed ID: 12951705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
